-
Antiviral API
- Arenavirus
- Cytomegalovirus (CMV)
- Endogenous Metabolite
- Enterovirus (EV)
- Epstein-Barr virus (EBV)
- Filovirus
- HCV Protease
- Hepatitis B Virus (HBV)
- Hepatitis C Virus (HCV)
- Herpes simplex Virus (HSV)
- HIF/HIF Prolyl-Hydroxylase
- HIV Integrase
- HIV Protease
- Human immunodeficiency Virus (HIV)
- Human papillomavirus (HPV)
- Influenza Virus
- Orthopoxvirus
- Others
- Respiratory syncytial Virus (RSV)
- Reverse Transcriptases (RTs)
- SARS-CoV
- Virus Protease
- Antiviral intermediates
ZINC000104379474
| Category | SARS-CoV |
| Description | ZINC000104379474 is a compound that targets SARS-CoV-2 endoribonuclease. |
Product Information
| Synonyms | ZINC000104379474|CS-0567635 |
| Molecular Weight | 559.57 |
| Molecular Formula | C27H33N3O10 |
| Canonical SMILES | CC1(C2CC3C(C(=O)C(=C(C3(C(=O)C2=C(C4=C1C=CC=C4O)O)O)O)C(=O)NCNCCCC(=O)O)N(C)C)O |
| Purity | ≥98% (HPLC) |
| Solubility | In vitro: 10 mM in DMSO |
| Appearance | Solid powder |
| Storage | Store at -20°C |
| Complexity | 1170 |
| Exact Mass | 559.21659426 |
| In Vitro | ZINC000104379474 shows inhibition against the SARS-CoV-2 virus in VERO E6 cells with IC50 and CC50 values of 0.01 and 0.9 mg/mL, respectively. |
| Target | SARS-CoV |
| XLogP3-AA | -4.3 |
